Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-01-08 @ 7:05 PM
Study NCT ID:
NCT03800134
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-11
First Post:
2018-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-09-11
Completion Date Type:
ESTIMATED
First Submit Date:
2018-12-07
First Submit QC Date:
None
Study First Post Date:
2019-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-11-22
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-06-10
Last Update Post Date:
2025-06-11
Last Update Post Date Type:
ACTUAL